Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury
about
Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivoThe response-to-retention hypothesis of early atherogenesisType VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injuryImplications of autophagy for vascular smooth muscle cell function and plasticityThe discoidin domain receptor tyrosine kinase DDR1 in arterial wound repairDecorin mimic regulates platelet-derived growth factor and interferon-γ stimulation of vascular smooth muscle cellsMultiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells.Redox control of vascular smooth muscle migration.PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stressPathological effects of pulmonary vein beta-radiation in a swine model.Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteriesRestenosis after balloon angioplasty and/or stent insertion - origin and prevention.Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation.The matricellular protein Cyr61 is a key mediator of platelet-derived growth factor-induced cell migrationCharacterization of Pdgfrb-Cre transgenic mice reveals reduction of ROSA26 reporter activity in remodeling arteries.Vascular wound healing and neointima formation induced by perivascular electric injury in mice.Identification of platelet-derived growth factor A and B chains in human renal vascular rejectionEstradiol attenuates directed migration of vascular smooth muscle cells in vitroBlockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.Chimera analysis supports a predominant role of PDGFRbeta in promoting smooth-muscle cell chemotaxis after arterial injury.Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation.Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation.Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study.Potential Role of Axonal Chemorepellent Slit2 in Modulating Adventitial Inflammation in a Rat Carotid Artery Balloon Injury Model.Induction of vascular atrophy as a novel approach to treating restenosis. A reviewMitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation.Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination.Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients.Impaired arterial neointima formation in mice with disruption of the plasminogen gene.Signal transduction for PDGF-induced chemotaxis of vascular smooth muscle cells.Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.Matrix metalloproteinases and coronary artery disease: a novel therapeutic target.Mechanisms of neointima formation--lessons from experimental models.In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty.Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia.Increasing our IQ of vascular smooth muscle cell migration with IQGAP1. Focus on "IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury".
P2860
Q24306656-7F7A41E1-12C2-4001-9A10-A9A713188BA4Q24629974-F3A0D4CC-EE60-4BD0-B63E-83D3FB824A31Q24669720-6614C2C7-E03B-44EE-8AD1-C305AAB1ECC1Q26863422-4140067B-0651-428C-8D01-D067AAF14A2BQ28360490-607E82C0-3170-4BCB-B457-7E6B74FE2F59Q28658459-6DCD45FF-11AB-4316-AA28-88F7F950F50BQ30441514-382730EE-B975-4700-A498-9DD6162849FEQ33690103-E0CDAC54-5274-4DE5-B925-75EED2112CDBQ33696216-B99338C0-7B90-4B1A-9F20-5721A48AF3E5Q33845001-98B7DCE9-01AA-48B7-9E03-B77AD9228B5EQ34405720-83A553A6-EA65-48D2-9858-55FE1BD19F85Q34992542-0F31BC91-B964-4EBF-8175-4C6ABBCEC24CQ35194484-A8DBB816-4BBE-4D1A-827D-9BE193D1CDD6Q35221544-9DAF20DD-8F2E-4BD7-A568-FBE7F3A1CF52Q35627738-6FD49BF1-ADF1-47A1-B03B-6DA5605F8D4CQ35764669-A94C3CB7-1CDF-4D5B-ADAA-71E9437A875FQ35774099-98CD7334-0936-470A-904E-9668E0FAC7C0Q35774287-154C569E-128F-4804-ADBD-D7FCD853B41BQ35789286-905D9C2B-A609-447B-8555-37CFB5CAA4E8Q35791966-724448EF-B703-4E97-912D-C0436891719BQ35829683-1B6E1779-D616-4412-B3F4-148047335D38Q36007499-1D17DA29-B02E-4CCE-AD1D-2A5A3F287EA0Q36176901-CE8F1A4B-71A1-4232-8639-3FDCE00E9745Q36330155-C3B07F3F-1BA3-47F0-AE46-6168977026BBQ36832265-D432087B-0E9B-4673-899A-1738D187431BQ36885396-50603F6B-B9A4-48BD-8959-DD2C5202BB10Q36976632-AF9F0D0D-A5AA-47F1-B55F-F07B2C265807Q37331731-290F5B54-3111-4995-93AB-FCA560BA0FE6Q37357738-0291986B-F99C-4A8E-9695-15AE59CCA3BBQ37447644-6415906A-61DB-42AC-9075-98CB62900BF7Q38112038-B432F5EB-F2A7-4EC3-A2E9-F2E91B191DFAQ38991475-F5C90C98-D485-4006-AEC2-B4C0B3CB9AEDQ39776706-C71A78A9-CBE5-4FD2-A1FA-81370C4646B1Q41500587-89E1C1E0-41FC-4888-8BC8-8C771C129092Q41500641-F49F0224-2D40-4F6E-B794-62A7D2218556Q41722548-92DDB9C0-7202-4755-BCFF-5847DE8FA873Q41740450-DE7DFDF1-BFFA-43DF-AA24-7AB353C58EEEQ42049615-0F5BB518-6460-4461-A9D6-BD52D5122AFAQ42102932-CD595B9D-F4B6-46CB-9576-BE5C143B89BEQ42582634-DB97A506-771D-47CB-A90A-40B9F49AC621
P2860
Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury
description
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1993
@ast
scientific journal article
@en
vedecký článok (publikovaný 1993/08/01)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/08/01)
@nl
наукова стаття, опублікована в серпні 1993
@uk
مقالة علمية (نشرت في أغسطس 1993)
@ar
name
Role of endogenous platelet-de ...... after balloon catheter injury
@ast
Role of endogenous platelet-de ...... after balloon catheter injury
@en
Role of endogenous platelet-de ...... after balloon catheter injury
@nl
type
label
Role of endogenous platelet-de ...... after balloon catheter injury
@ast
Role of endogenous platelet-de ...... after balloon catheter injury
@en
Role of endogenous platelet-de ...... after balloon catheter injury
@nl
prefLabel
Role of endogenous platelet-de ...... after balloon catheter injury
@ast
Role of endogenous platelet-de ...... after balloon catheter injury
@en
Role of endogenous platelet-de ...... after balloon catheter injury
@nl
P2093
P356
P1476
Role of endogenous platelet-de ...... after balloon catheter injury
@en
P2093
C. L. Jackson
E. W. Raines
M. A. Reidy
P304
P356
10.1161/01.ATV.13.8.1218
P577
1993-08-01T00:00:00Z